NYSE:QGENLife Sciences
Qiagen’s US$500 Million Synthetic Buyback Might Change The Case For Investing In Qiagen (QGEN)
In December 2025, QIAGEN announced it would return about US$500,000,000 to shareholders through a synthetic share repurchase that combines a direct capital repayment with a reverse stock split, aiming to cut its share count by roughly 5% by early January 2026.
This move means QIAGEN will have already exceeded its pledge to return at least US$1.00 billion to shareholders by the end of 2028, and it is now considering further ways to increase shareholder returns from 2026 onward.
We’ll now...